Brevan Howard Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $616K | Buy |
43,934
+3,316
| +8% | +$46.5K | ﹤0.01% | 1177 |
|
|
2025
Q1 | $635K | Buy |
+40,618
| New | +$635K | 0.01% | 614 |
|
|
2024
Q4 | – | Sell |
-35,147
| Closed | -$327K | – | 1000 |
|
|
2024
Q3 | $327K | Sell |
35,147
-52,683
| -60% | -$490K | ﹤0.01% | 762 |
|
|
2024
Q2 | $817K | Buy |
+87,830
| New | +$817K | 0.01% | 388 |
|
|
2024
Q1 | – | Sell |
-51,442
| Closed | -$166K | – | 957 |
|
|
2023
Q4 | $166K | Buy |
+51,442
| New | +$166K | ﹤0.01% | 857 |
|